A typical application of REVITY begins with layering, or irrigating, varying amounts, usually less than one milliliter, directly onto the surface of the damaged dermal tissue. This is performed after the chosen method of sharp debridement is performed. The product is left in place for 15 – 60 seconds then is removed with a water rinse.
REVITY can be characterized by its functionality as a clinical tool that was designed to perform controlled, intense, instantaneous water extraction from the topmost layer of necrotized tissue on a lesion surface. REVITY is a therapeutic instrument used to instantaneously convert necrotized tissues, microbial biofilm and other proinflammatory pathogenic substances on the surface of a dermal lesion into a harmless devitalized tissue coagulum whenever and wherever that would be beneficial. It is expected that users of REVITY will adapt specific application techniques to best fit their own treatment protocols to provide the greatest clinical benefit possible to their patients.
REVITY is currently in the regulatory pathway for clearance in US and outside US. REVITY is not currently FDA cleared for wound care.